Skip to main content
. 2019 Feb 1;33(1):1–7. doi: 10.3341/kjo.2018.0010

Fig. 1. Before and after injection of botulinum neurotoxin type A (BoNT-A) and hyaluronic acid. (A–F) The patients with only facial nerve palsy. (G,H) The patient with facial nerve palsy and other cranial nerve paralysis. (A) A 1-year-old male patient who had postpartum right facial nerve injury. (B) A 8-year-old male patient who had postpartum right facial nerve injury after 7 years of injection of BoNT-A and hyaluronic acid. (C) A 70-yearold female patient who had right facial nerve palsy. (D) A 70-year-old female patient who had right facial nerve palsy after 3 months of injection of BoNT-A and hyaluronic acid. (E) A 78-year-old male patient who had left facial nerve palsy. (F) A 78-year-old male patient who had left facial nerve palsy after 3 months of injection of BoNT-A and hyaluronic acid. (G) A 42-year-old male patient who had brain tumor surgery and had facial nerve palsy and other cranial nerve palsy. (H) A 42-year-old male patient who had brain tumor surgery and had facial nerve palsy and other cranial nerve palsy after 1 month of injection of BoNT-A at extraocular muscle and hyaluronic acid at left upper and lower lid. Informed consent was obtained from all study participants.

Fig. 1